Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1958103

CCCCCCCCCCCCCCCCCCCCCC(N)=O.CCC[N+](C)(C)C(O)CC.[Cl-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.46
MEN1 O00255 1/20 0.46
FAAH O00519 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.39
CES2 O00748 2/20 0.38
CES1 P23141 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4660135 0.98 SOAT1 (0.47) SOAT1MEN1FAAHTP53CYP1A2
Hydrochloric Acid SCHEMBL28502738 0.92 FAAH (0.62) SOAT1MEN1FAAHTP53CYP1A2
Oleamide SCHEMBL28516627 0.92 FAAH (0.62) SOAT1MEN1FAAHTP53CYP1A2
Oleamide SCHEMBL28927356 0.90 FAAH (0.64) SOAT1MEN1FAAHTP53CYP1A2
Palmitamide SCHEMBL28980258 0.85 SOAT1 (0.47) SOAT1MEN1FAAHTP53CYP1A2
Palmitamide SCHEMBL27825196 0.85 SOAT1 (0.50) SOAT1MEN1FAAHTP53CYP1A2
Hydrochloric Acid SCHEMBL1705678 0.79 SOAT1 (0.55) SOAT1MEN1FAAHTP53CYP1A2
Octadecanoic Acid Amide SCHEMBL5346586 0.79 SOAT1 (0.55) SOAT1MEN1FAAHTP53CYP1A2
Hydrochloric Acid SCHEMBL28807747 0.79 SOAT1 (0.55) SOAT1MEN1FAAHTP53CYP1A2
Palmitamide SCHEMBL3831146 0.79 SOAT1 (0.55) SOAT1MEN1FAAHTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099955-A1 SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF HTL BIOTECHNOLOGY INNOVATION INC. 2024-03-28 US disclosed
EP-4288084-A1 SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF Modern Meadow, Inc. (US) 2023-12-13 EP disclosed
EP-3398585-B1 EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME HAYASHIBARA CO (JP) 2020-02-26 EP disclosed
US-20190008747-A1 EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME Hayashibara Co., Ltd. (JP) 2019-01-10 US disclosed
EP-3398585-A1 EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME Hayashibara Co., Ltd. (JP) 2018-11-07 EP disclosed
US-10111822-B2 External dermal composition for anti-ageing and method for producing the same Hayashibara Co., Ltd. (JP) 2018-10-30 US disclosed
EP-2939657-B1 SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR HAYASHIBARA CO (JP) 2018-08-08 EP disclosed
EP-2516510-B1 SURFACE-TREATMENT AGENT FOR POWDER FOR USE IN COSMETIC AND COSMETIC CONTAINING POWDER TREATED WITH THE SAME DOW CORNING TORAY CO LTD (JP) 2017-01-25 EP disclosed
EP-2515841-B1 COPOLYMER HAVING CARBOSILOXANE DENDRIMER STRUCTURE, AND COMPOSITION AND COSMETIC CONTAINING THE SAME DOW CORNING TORAY CO LTD (JP) 2016-12-21 EP disclosed
US-9260607-B2 Surface-treatment agent for powder for use in cosmetic and cosmetic containing powder treated with the same DOW CORNING TORAY CO., LTD. (JP) 2016-02-16 US disclosed
US-9221952-B2 Linear and cyclic siloxanes and cosmetic compositions made thereof DOW CORNING TORAY CO., LTD. (JP) 2015-12-29 US disclosed
US-20150342854-A1 EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME Hayashibara Co., Ltd. (JP) 2015-12-03 US disclosed
EP-2939657-A1 SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR Hayashibara Co., Ltd. (JP) 2015-11-04 EP disclosed
US-20120263662-A1 Copolymer Having Carbosiloxane Dendrimer Structure, And Composition And Cosmetic Containing The Same DOW TORAY CO., LTD. (JP) 2012-10-18 US disclosed
EP-2507248-A1 LINEAR AND CYCLIC SILOXANES AND COSMETIC COMPOSITIONS MADE THEREOF Dow Corning Toray Co., Ltd. (JP) 2012-10-10 EP disclosed
US-20120251605-A1 Surface-Treatment Agent For Powder For Use In Cosmetic And Cosmetic Containing Powder Treated With The Same DOW TORAY CO., LTD. (JP) 2012-10-04 US disclosed
US-20120237583-A1 Linear And Cyclic Siloxanes And Cosmetic Compositions Made Thereof DOW TORAY CO., LTD. (JP) 2012-09-20 US disclosed
WO-2011068250-A1 LINEAR AND CYCLIC SILOXANES AND COSMETIC COMPOSITIONS MADE THEREOF DOW CORNING TORAY CO., LTD. (JP) 2011-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120263662-A1 Copolymer Having Carbosiloxane Dendrimer Structure, And Composition And Cosmetic Containing The Same TAS2R8, CUTA, TAS2R43 SOAT1 4315/4885MEN1 2663/4885FAAH 4526/4885
US-20120237583-A1 Linear And Cyclic Siloxanes And Cosmetic Compositions Made Thereof TAS2R8, TAS2R5, TAS2R7 SOAT1 4606/4885MEN1 656/4885FAAH 3841/4885
US-20120251605-A1 Surface-Treatment Agent For Powder For Use In Cosmetic And Cosmetic Containing Powder Treated With The Same CUTA, GPKOW, TAS2R8 SOAT1 3059/4885MEN1 3148/4885FAAH 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.